Priority Date: 21.10.08 (US 20080196945P)

Combination of the peptide epoxyketone proteasome inhibitor carfilzomib with melphalan for use in the treatment of cancer

  • Application ID: EP14171395
  • Status: PATENT GRANTED

Attorney

Employment test 51 - 200 employees
Company dna hoffmann eitle
operating since 1892
Headquarter in Munich and 6 offices
active in Legal Services and IP Portfolio Processing

Specialization

This EP application has the IPC class A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE). Here you find a list of all patent agent firms which are specialized in this IPC class. For a similar patent, they might be a good choice.

Timeline

  • 21.10.2008 - Priority Date (US 20080196945P)
  • 29.10.2014 - Publication A1 (EP2796134)
  • 07.12.2016 - Publication B1 (EP2796134)